Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

SciSparc Ltd. - Ordinary Shares (NQ: SPRC )

3.680 +0.180 (+5.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 119,472
Open 3.250
Bid (Size) 3.480 (1)
Ask (Size) 3.870 (4)
Prev. Close 3.500
Today's Range 3.210 - 3.800
52wk Range 0.1407 - 4.650
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SciSparc Initiated Its Clinical Trial with SCI-210 in Pediatrics with Autism Spectrum Disorder
From SciSparc Ltd
Via GlobeNewswire
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant... 
Via Benzinga

Performance

YTD
+400.48%
+400.48%
1 Month
+2271.13%
+2271.13%
3 Month
+569.09%
+569.09%
6 Month
+728.46%
+728.46%
1 Year
+332.94%
+332.94%

More News

Read More
Crude Oil Rises Sharply; Know Labs Shares Plunge
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Dow Falls Over 100 Points; US Durable Goods Orders Increase In August
Via Benzinga
Topics Stocks
Exposures US Equities
US Stocks Open Higher; Costco Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
SciSparc Announces Expected Implementation of 1-for-26 Reverse Share Split
From SciSparc Ltd
Via GlobeNewswire
SciSparc Announces 1-for-26 Reverse Share Split
From SciSparc Ltd
Via GlobeNewswire
SciSparc Engages Investment Bank to Identify Potential Strategic Transaction Opportunities
From SciSparc Ltd
Via GlobeNewswire
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nasdaq Grants SpiSparc, Ltd. Extension To Maintain Listing: +600% Bid Price Surge Needed
Via Benzinga
SciSparc Announces Initiation of Randomized Phase IIb Clinical Trial of its Proprietary SCI-110 for Tourette Syndrome
From SciSparc Ltd
Via GlobeNewswire
SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
From SciSparc Ltd
Via GlobeNewswire
Why Mitek Systems Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Why Affirm Holdings Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Cannabis Stock Gainers And Losers From August 24, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Aegis Capital Corp. acted as Sole Bookrunner on a $1.3 Million Underwritten Public Offering for SciSparc Ltd. (NASDAQ: SPRC)
Via ACCESSWIRE
SciSparc Ltd. Closes $1.3 Million Underwritten Public Offering
From SciSparc Ltd
Via GlobeNewswire
Marijuana Stock Movers For August 22, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From August 14, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.